Céline E. Toutain

Animal Health Institute — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

10h-index569citations23works2.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Angiogenesis and VEGF in Cancer(5), Inflammatory mediators and NSAID effects(4), Menopause: Health Impacts and Treatments(3), Estrogen and related hormone effects(3), Drug-Induced Adverse Reactions(3)

Publications23 total

Pharmacokinetics of Ilunocitinib, a New Janus Kinase Inhibitor, in Dogs
Journal of Veterinary Pharmacology and Therapeutics·2025· 1 citedOpen Access
Immunologic response to first booster vaccination in dogs treated with zenrelia™ (ilunocitinib tablets) at up to three times the recommended therapeutic dose compared to untreated controls
BMC Veterinary Research·2025· 1 citedOpen Access
Safety of ilunocitinib tablets (Zenrelia™) after once daily oral administration in dogs
BMC Veterinary Research·2025· 6 citedOpen Access
The Caenorhabditis elegans DEG-3/DES-2 Channel Is a Betaine-Gated Receptor Insensitive to Monepantel
Molecules·2022· 6 citedOpen Access
DEG-3/DES-2 is a monepantel-insensitive betaine-gated receptor from Caenorhabditis elegans
Research at the University of Copenhagen (University of Copenhagen)·2022
Safety evaluation of the interchangeable use of robenacoxib in commercially-available tablets and solution for injection in cats
BMC Veterinary Research·2020· 5 citedOpen Access
Six-month safety evaluation of robenacoxib tablets (Onsior™) in dogs after daily oral administrations
BMC Veterinary Research·2018· 10 citedOpen Access
Pharmacokinetics of lotilaner following a single oral or intravenous administration in cats
Parasites & Vectors·2018· 16 citedOpen Access
Safety evaluation of the interchangeable use of robenacoxib (Onsior™) tablets and solution for injection in dogs
BMC Veterinary Research·2017· 11 citedOpen Access
The intravenous and oral pharmacokinetics of lotilaner in dogs
Parasites & Vectors·2017· 61 citedOpen Access
Testosterone Prevents Cutaneous Ischemia and Necrosis in Males Through Complementary Estrogenic and Androgenic Actions
Arteriosclerosis Thrombosis and Vascular Biology·2017· 21 citedOpen Access
Multiple comparison procedure and modeling: a versatile tool for evaluating dose–response relationships in veterinary pharmacology – a case study with furosemide
Journal of Veterinary Pharmacology and Therapeutics·2016· 7 cited
Chronic estradiol treatment reduces platelet responses and protects mice from thromboembolism through the hematopoietic estrogen receptor α
Blood·2012· 60 citedOpen Access
Activation function 2 (AF2) of estrogen receptor-α is required for the atheroprotective action of estradiol but not to accelerate endothelial healing
Proceedings of the National Academy of Sciences·2011· 114 citedOpen Access
Paw Inflammation Model in Dogs for Preclinical Pharmacokinetic/Pharmacodynamic Investigations of Nonsteroidal Anti-Inflammatory Drugs
Journal of Pharmacology and Experimental Therapeutics·2011· 35 citedOpen Access
254 Estrogen Receptor α expression in both endothelium and hematopoietic cells is required for the accelerative effect of estradiol on reendothelialization
Archives of Cardiovascular Diseases Supplements·2010· 1 cited
Estrogen Receptor α Expression in Both Endothelium and Hematopoietic Cells Is Required for the Accelerative Effect of Estradiol on Reendothelialization
Arteriosclerosis Thrombosis and Vascular Biology·2009· 54 cited
K005 Estradiol accelerates reendothelialization through a cooperative effect between bone marrow and endothelial cells expressing estrogen receptor alpha
Archives of cardiovascular diseases·2009
F002 Prevention of skin flap necrosis by estradiol involves reperfusion of a protected vascular network
Archives of cardiovascular diseases·2009
Effets vasculoprotecteurs des oestrogènes dans l'ischémie cutanée et après agression artérielle
Thèses en ligne de l'Université Toulouse III (Université Toulouse III)·2009Open Access
page 1 of 2Next →

Frequent Co-authors

Françoise Lenfant(9), Jean‐François Arnal(9), Pierre Gourdy(6), Coralie Fontaine(3), L. Brouchet(3), Isabelle Raymond‐Letron(3), Patricia Vicendo(3), Wolfgang Seewald(3), Stephen King(3), Rainer Helbig(3), Andrée Krust(2), Hortense Bergès(2), Alain‐Pierre Gadeau(2), Pierre Chambon(2), Julie Favre(2), Martin Jung(2), Cédric Filipe(2), Mark C. Heit(2), Tina Vicky Alstrup Hansen(2), Heinz Sager(2)